Fact CheckerSign in

NCT07402850Completed

Oscillating Positive Expiratory Pressure Therapy Versus Autogenic Drainage in Patients With COPD

Oscillating Positive Expiratory Pressure Therapy Versus Autogenic Drainage in Patients With Chronic Obstructive Pulmonary Disease: Effects on Pulmonary Function, Sputum Clearance, Dyspnea, and Quality of Life

Source: ClinicalTrials.gov · Last updated 11 Feb 2026

Brief summary (registry, in English)

Chronic Obstructive Pulmonary Disease (COPD) is a long-term lung condition that causes breathing difficulty, cough, and sputum production. Airway clearance techniques are commonly used to help reduce symptoms and improve breathing in patients with COPD. This study compared two airway clearance methods-oscillating positive expiratory pressure (OPEP) therapy and autogenic drainage-to determine which method is more effective in improving lung function, sputum clearance, shortness of breath, and quality of life in patients with COPD. Participants were divided into two groups and received either OPEP therapy or autogenic drainage for four weeks. Outcomes were measured at the beginning of the study and again after completion of the intervention. The findings of this study aim to support evidence-based physiotherapy management for patients with COPD.

Status (registry)
Completed
Study type
Interventional
Enrollment
58 (actual)
First submitted
26 Jan 2026
Start date
5 May 2025
Primary completion date
8 Aug 2025
Lead sponsor
Adnan Hashim
Diseases
COPD
NCT number
NCT07402850

What you commit to

  • Study type: Interventional
  • Participants enrolled: 58
  • From 5 May 2025 to the primary completion date, 8 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Recent thoracic or abdominal surgery

Other illness

  • Severe cardiovascular, neurological, or musculoskeletal disorders
  • Presence of other significant respiratory diseases

Other

  • Acute exacerbation of COPD
  • Unwillingness to participate or inability to comply with the study protocol

Who the study is looking for

  • Age between 35 and 50 years
  • Both genders
  • Participants must have a confirmed diagnosis of Chronic Obstructive Pulmonary Disease (COPD) based on the GOLD 2023 guidelines
  • Clinically stable
  • History of Sputum Culture

Age in the registry: 35 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University
Coordinator of this site? Confirm its status
LahorePakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.